{"id":"NCT02104804","sponsor":"AstraZeneca","briefTitle":"Evaluate the Efficacy and Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin Combined With Metformin in Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control","officialTitle":"A Multicenter, Randomized, Double-Blind, Phase 3b Trial to Evaluate the Efficacy and Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin in Combination With Metformin in Chinese Subjects in China With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Insulin Alone or on Insulin in Combination With Metformin","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-05-07","primaryCompletion":"2016-02-26","completion":"2016-02-26","firstPosted":"2014-04-04","resultsPosted":"2017-10-02","lastUpdate":"2017-10-02"},"enrollment":953,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"Saxagliptin 5mg","otherNames":["Insulin: intermediate-acting or basal or premixed ( include short- or rapid-acting insulin as one component). ≥20 unit/day, ≤150 units/day","Metformin: Glucophage, 500-2500mg/day"]},{"type":"DRUG","name":"Placebo for Saxagliptin","otherNames":["Insulin: intermediate-acting or basal or premixed ( include short- or rapid-acting insulin as one component). ≥20 unit/day, ≤150 units/day","Metformin: Glucophage, 500-2500mg/day"]}],"arms":[{"label":"Saxagliptin 5mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"A Multicenter, Randomized, Double-Blind, Phase 3b Trial to Evaluate the Efficacy and Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin in Combination with Metformin in Chinese Subjects in China with Type 2 Diabetes Who Have Inadequate Glycaemic Control on Insulin Alone or on Insulin in Combination with Metformin","primaryOutcome":{"measure":"Change in HbA1c From Baseline to Week 24","timeFrame":"Baseline to 24 weeks","effectByArm":[{"arm":"Saxagliptin Plus Insulin","deltaMin":-0.64,"sd":null},{"arm":"Vs. Placebo Plus Insulin","deltaMin":-0.06,"sd":null}],"pValues":[{"comp":"OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":11,"countries":["China"]},"refs":{"pmids":["17337495","1244564","17387446","22081481","20092585","21871686","29144061"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":14,"n":231},"commonTop":["Hypoglycaemia","Upper respiratory tract infection","Nasopharyngitis","Urinary tract infection","Cough"]}}